tiprankstipranks
Trending News
More News >
Tri Chemical Laboratories Inc. (JP:4369)
:4369
Japanese Market

Tri Chemical Laboratories Inc. (4369) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4369

Tri Chemical Laboratories Inc.

(4369)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 4o)
Rating:72Outperform
Price Target:
¥3,311.00
▲(30.35% Upside)
Tri Chemical Laboratories Inc. has a strong financial foundation with robust profitability and a stable balance sheet, but faces challenges in cash flow management. Technical indicators suggest short-term bullish momentum, while valuation metrics indicate the stock is fairly priced. The absence of earnings call and corporate events data limits further insights.
Positive Factors
Revenue Growth
Steady revenue growth suggests sustained demand for Tri Chemical's products and services, supporting long-term business expansion.
Profitability
High profitability margins indicate efficient operations and strong market positioning, which can drive future earnings growth.
Balance Sheet Strength
A robust balance sheet with low leverage enhances financial stability and provides flexibility for future investments.
Negative Factors
Cash Flow Management
Challenges in generating free cash flow may hinder the company's ability to invest in growth opportunities and manage financial obligations.
Cost Pressures
Declining gross margins suggest rising costs, which could pressure profitability if not managed effectively over time.
Debt Increase
An increase in debt, although slight, requires careful management to maintain financial health and avoid potential leverage risks.

Tri Chemical Laboratories Inc. (4369) vs. iShares MSCI Japan ETF (EWJ)

Tri Chemical Laboratories Inc. Business Overview & Revenue Model

Company DescriptionTri Chemical Laboratories Inc. is a leading provider of specialty chemicals and chemical services, primarily serving the agriculture, industrial, and environmental sectors. The company focuses on developing innovative chemical solutions that enhance product performance and operational efficiency for its clients. Core offerings include custom chemical formulations, analytical testing services, and regulatory compliance assistance, aimed at facilitating a wide range of applications from crop protection to water treatment.
How the Company Makes MoneyTri Chemical Laboratories generates revenue through multiple streams, including the sale of specialty chemical products, analytical testing services, and consulting on regulatory compliance. The primary revenue comes from direct sales of its custom chemical formulations to agricultural businesses and industrial clients. Additionally, the company earns income from its laboratory services, which provide essential testing and analysis for clients in various sectors. Strategic partnerships with agricultural and industrial firms enhance its market reach, while ongoing investments in research and development allow Tri Chemical to innovate and introduce new products, further driving revenue growth.

Tri Chemical Laboratories Inc. Financial Statement Overview

Summary
Tri Chemical Laboratories Inc. demonstrates strong revenue growth and profitability, supported by a solid balance sheet with low leverage. However, cash flow challenges, particularly negative free cash flow, could pose risks if not addressed. Overall, the company is financially sound but should focus on improving cash flow management to sustain growth.
Income Statement
85
Very Positive
Tri Chemical Laboratories Inc. shows strong revenue growth with a 17.43% increase in TTM, indicating robust demand. The company maintains healthy profitability with a gross profit margin of 41.64% and a net profit margin of 24.13% in TTM. EBIT and EBITDA margins are also solid at 30.16% and 36.65%, respectively, reflecting efficient operations. However, slight declines in gross and net profit margins compared to previous periods suggest potential cost pressures.
Balance Sheet
78
Positive
The balance sheet is strong with a low debt-to-equity ratio of 0.0468, indicating low leverage and financial stability. Return on equity is healthy at 17.64%, showcasing effective use of equity to generate profits. The equity ratio stands at 80.71%, reflecting a solid equity base. However, the slight decrease in stockholders' equity over recent periods could be a point of concern.
Cash Flow
65
Positive
Operating cash flow remains positive, but the free cash flow is negative, indicating potential challenges in cash generation after capital expenditures. The operating cash flow to net income ratio is 0.36, suggesting moderate cash conversion efficiency. The negative free cash flow growth rate and free cash flow to net income ratio highlight potential liquidity concerns.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue23.81B18.91B11.25B13.80B11.57B9.80B
Gross Profit9.40B8.01B4.09B5.58B4.84B4.38B
EBITDA8.33B6.63B4.61B7.42B6.35B5.17B
Net Income5.76B4.96B2.47B4.83B4.10B3.38B
Balance Sheet
Total Assets42.19B36.94B31.86B32.12B28.29B19.87B
Cash, Cash Equivalents and Short-Term Investments5.42B9.44B10.50B11.14B8.03B1.70B
Total Debt4.24B1.78B2.40B3.24B4.28B5.05B
Total Liabilities7.67B5.36B4.29B6.24B6.97B7.27B
Stockholders Equity34.52B31.59B27.57B25.88B21.32B12.60B
Cash Flow
Free Cash Flow-5.86B605.75M1.19B4.84B2.71B-872.24M
Operating Cash Flow1.07B3.68B2.97B6.39B3.64B2.09B
Investing Cash Flow-7.69B-3.12B-1.78B-1.56B-932.88M-2.96B
Financing Cash Flow1.09B-1.62B-1.86B-1.70B3.59B948.34M

Tri Chemical Laboratories Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2540.00
Price Trends
50DMA
2867.88
Negative
100DMA
2936.79
Negative
200DMA
2926.31
Negative
Market Momentum
MACD
-65.94
Positive
RSI
35.38
Neutral
STOCH
7.29
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4369, the sentiment is Negative. The current price of 2540 is below the 20-day moving average (MA) of 2835.70, below the 50-day MA of 2867.88, and below the 200-day MA of 2926.31, indicating a bearish trend. The MACD of -65.94 indicates Positive momentum. The RSI at 35.38 is Neutral, neither overbought nor oversold. The STOCH value of 7.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4369.

Tri Chemical Laboratories Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥64.04B8.012.02%-4.42%10.23%
74
Outperform
¥109.95B7.904.18%1.16%167.89%
72
Outperform
¥82.54B14.341.38%47.56%49.58%
71
Outperform
¥123.36B15.091.81%-0.52%5.18%
68
Neutral
¥73.61B11.903.75%-0.68%-9.93%
66
Neutral
¥17.47B9.233.28%13.09%89.45%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4369
Tri Chemical Laboratories Inc.
2,540.00
-163.37
-6.04%
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
5,330.00
903.04
20.40%
JP:4028
ISHIHARA SANGYO KAISHA, LTD.
2,752.00
1,336.55
94.43%
JP:4099
SHIKOKU KASEI HOLDINGS CORPORATION
2,762.00
787.23
39.86%
JP:4113
Taoka Chemical Co., Ltd.
1,219.00
242.16
24.79%
JP:4365
Matsumoto Yushiseiyaku Co., Ltd.
19,790.00
1,710.89
9.46%

Tri Chemical Laboratories Inc. Corporate Events

Tri Chemical Laboratories Reports Strong Financial Growth for Nine Months Ending October 2025
Nov 28, 2025

Tri Chemical Laboratories Inc. reported its consolidated financial results for the nine months ended October 31, 2025, showing significant growth in net sales and profits compared to the previous year. The company achieved a 37.4% increase in net sales and a 30.2% rise in operating profit, indicating strong operational performance and market demand. Additionally, the company’s total assets increased, reflecting a robust financial position. The inclusion of a new subsidiary, AD-Trichem (Anhui) Electronic Materials Co., Ltd., highlights the company’s expansion efforts in the electronic materials sector.

Tri Chemical Laboratories Secures Financing for New Plant Construction
Sep 12, 2025

Tri Chemical Laboratories Inc. has announced the execution of a term-loan agreement and a commitment-line agreement to fund the construction of a new plant in Minami-Alps City, Yamanashi Prefecture. These agreements, totaling 10 billion yen, are designed to secure the necessary capital for growth and expansion, with minimal expected impact on the company’s current fiscal performance.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025